Tevogen Bio company information, Employees & Contact Information

Tevogen Updates on TVGN 489 Following Growing Long COVID Patient Interest GlobeNewswire

Tevogen Updates on TVGN 489 Following Growing Long COVID Patient Interest Stock Titan

Tevogen Recognized in BINJE’s BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma Yahoo Finance

Tevogen Bio Reaffirms Investor Confidence with Estimated Asset Value Exceeding $10 Billion FinancialContent

Tevogen Bio Holdings Inc. Secures $50 Million Agreement with CD8 Technology Services to Enhance R&D and Manufacturing Capabilities Quiver Quantitative

Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Join GlobeNewswire

Tevogen Bio Announces 2025 Annual Meeting GlobeNewswire

Tevogen Bio Holdings Inc. Outlines Strategic Growth and Advancements in AI-Driven Healthcare Solutions Quiver Quantitative

Tevogen Bio Founder and CEO Dr. Ryan Saadi Named to 2025 GlobeNewswire

PRN_FinancialWrapper FinancialContent

Tevogen Bio Highlights Promising Clinical Results for TVGN 489 in Treating SARS-CoV-2 in Immunocompromised Patients | TVGN Stock News Quiver Quantitative

Tevogen Bio Holdings Inc. Thanks HHS for Supporting Long COVID Research and Highlights Potential of TVGN 489 Therapy Quiver Quantitative

Tevogen Bio Holdings Inc. Highlights Internally Developed Assets Reflecting Long-Term Value | TVGN Stock News Quiver Quantitative

Tevogen Bio Holdings Inc. Reports 24% Increase in Institutional Ownership in Q2 2025 Quiver Quantitative

Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company’s Novel Business Model as Key to Sustainable Success through Patient Affordability The Globe and Mail

6.7 Billion Records: Tevogen's PredicTcell AI Platform Makes Breakthrough in T Cell Therapy Precision Stock Titan

Tevogen Bio Holdings Inc. Secures $1 Million Grant to Advance AI-Driven Drug Discovery Initiative | TVGN Stock News Quiver Quantitative

Tevogen.AI Launches PredicTcell Model to Transform Drug Discovery and Accelerate Cancer Immunotherapy Development | TVGN Stock News Quiver Quantitative

Tevogen Bio Announces Publication of Positive Phase I Clinical Trial Results for TVGN 489 in Blood Advances Yahoo Finance

Microsoft-Powered AI Breakthrough: Tevogen's New Patent Could Revolutionize Drug Development Stock Titan

20M Americans Affected: Tevogen's T Cell Therapy TVGN 489 Shows Breakthrough in Long COVID Treatment Stock Titan

Tevogen Transforms into AI Powerhouse: $36B Revenue Target as Company Doubles HQ Size Stock Titan

Tevogen Bio's Revolutionary Cost Strategy Reshapes Biotech Economics While Chinese Rivals Surge Stock Titan

AI Drug Discovery Breakthrough: Tevogen Bio Receives Million-Dollar Grant to Transform Medicine Development Stock Titan

AI-Powered Cancer Breakthrough: Tevogen Bio Lands Major Funding for Next-Gen Treatment Platform Stock Titan

Tevogen Bio Holdings Inc., a Cell Therapy Company, GlobeNewswire

Tevogen Bio Appoints IT Expert and Leader Mittul Mehta as Chief Information Officer and Head of Tevogen.ai Initiative Business Wire

Tevogen Bio Appoints Globally Prominent Physicist Specializing in Space Biology, COVID-19, and AI Democratization, Afshin Beheshti, to Advisory Board The AI Journal

Tevogen Bio Congratulates Innovation and Public Health Advisory Board Chairperson, Professor Sten Vermund on Being Elected to Serve as President of the Global Virus Network FinancialContent

Tevogen Bio Appoints Three Prominent Healthcare Leaders to its Board of Directors Business Wire

Tevogen Bio Expresses Gratitude as CEO is Named Recipient of Boy Scouts of America Distinguished Citizen Award FinancialContent

Tevogen Bio Appoints Yale Public Health Dean Dr. Sten H. Vermund, Preeminent Global Expert in COVID-19 and Infectious Disease Epidemiology, to its Innovation and Public Health Advisory Council Business Wire